Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Zenas BioPharma
Zenas BioPharma
Zenas adds $200M series C to reach a bucket of key readouts for its lead monoclonal antibody
Fierce Biotech
Tue, 05/7/24 - 10:58 am
Zenas BioPharma
funding
monoclonal antibodies
obexelimab
autoimmune disease
Autoimmune Biotech Zenas Gets $118M to Take Antibody Drug Into Phase 3
MedCity News
Sun, 11/13/22 - 07:09 pm
Zenas BioPharma
funding
Juvena Therapeutics
NRG
Therapeutics
Sensorium Therapeutics
Zenas zips up $118M to launch phase 3 for rare autoimmune disease candidate
Fierce Biotech
Tue, 11/8/22 - 10:22 pm
Zenas BioPharma
Xencor
funding
autoimmune disease
Xencor finally finds buyer for onetime lead drug, offloading autoimmune asset to Tesaro co-founder in backloaded deal
Fierce Biotech
Mon, 11/22/21 - 10:37 am
Xencor
obexelimab
Zenas BioPharma
autoimmune disease